Cancer cells lacking p53 or having mutated p53 failed to increase SERCA activity and, thus, did not display increased mitochondrial Ca2+ overload, which contributed to the resistance of these cells to these toxic agents (119, 120). This evidence concerns the gene TP53 and cancer.